JW Pharmaceutical Corporation (KRX:001060)

Market Cap	525.71B -2.5%
Revenue (ttm)	820.86B +10.5%
Net Income	94.32B +94.6%
EPS	4,121.37 +93.9%
Shares Out	22.89M
PE Ratio	5.58
Forward PE	n/a
Dividend	650.00 (2.83%)
Ex-Dividend Date	Mar 31, 2026

Volume	27,530
Open	23,150
Previous Close	23,150
Day's Range	22,700 - 23,350
52-Week Range	21,550 - 39,250
Beta	1.02
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases, and pancreatic cancer. The company also provides infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is bas...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,049
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001060

Financial Performance

In 2025, JW Pharmaceutical's revenue was 775.30 billion, an increase of 7.77% compared to the previous year's 719.38 billion. Earnings were 57.43 billion, a decrease of -6.90%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error